Otros idiomas The Technology Co.,Ltd.

Acciones

A043090

KR7043090000

Precio de cierre Korea S.E. Otros sitios de cotización 00:00:00 17/07/2024			Varia. Cinco días.	Varia. 1 de enero.
393 ^KRW	0,00 %		-2,24 %	-38,59 %

2023	Exergy21 Co. Ltd. presenta los resultados del ejercicio finalizado el 31 de diciembre de 2022	CI
2021	Hanchang Biotech Co. (KOSDAQ:A043090) adquirió el 5,61% de Hanju Chemical Company Ltd por 2.700 millones de KRW.	CI

Otros idiomas

Desbloquee todas las noticias: ¡Sea el primero en enterarse y reaccione antes que los mercados!

Inscripción 100% Gratuita

PangSky Corp. announced that it has received KRW 1 billion in funding from Exergy21 Co., Ltd.	22/03
PangSky Corp. announced that it expects to receive KRW 1 billion in funding from Exergy21 Co., Ltd.	21/03
Exergy21 Co., Ltd. announced that it expects to receive KRW 24.999999475 billion in funding	18/08/23
Kattus Co., Ltd. announced that it has received KRW 5.999 billion in funding from Exergy21 Co., Ltd.	03/05/23
Kattus Co., Ltd. announced that it expects to receive KRW 5.999 billion in funding from Exergy21 Co., Ltd.	26/04/23
Exergy21 Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	21/03/23
Exergy21 Co., Ltd. announced that it expects to receive KRW 25 billion in funding	16/03/23
Hanchang Biotech Co., Ltd. announced that it has received KRW 15 billion in funding from Exergy21.Inc	17/10/22
HanChang Biotech to Raise $9.2 Million Through Stock Offering	05/08/22
Hanchang Corporation entered into an agreement to acquire 73.98% for KRW 25 billion.	05/08/22
Exergy21 Co., Ltd. announced that it expects to receive KRW 79.99999938 billion in funding from Jeonheung CNC Co., Ltd.	04/08/22
Hanchang Biotech Co., Ltd. announced that it expects to receive KRW 12.5 billion in funding from Jeonheung CNC Co., Ltd.	04/08/22
Hanchang Biotech Co., Ltd. announced that it expects to receive KRW 15 billion in funding from Exergy21.Inc	04/08/22
An undisclosed buyer agreed to acquire 8.6% stake in Hanchang Biotech Co., Ltd. from Hanchang Corporation for KRW 6.8 billion.	04/08/22
Hanchang Biotech Co., Ltd. announced that it expects to receive KRW 27.49999938 billion in funding	04/08/22
Hanchang Biotech Co., Ltd. announced that it expects to receive KRW 11.99999925 billion in funding from Jeonheung CNC Co., Ltd.	04/08/22
Hanchang Biotech Co., Ltd. announced that it expects to receive KRW 12.49999938 billion in funding from Jeonheung CNC Co., Ltd.	04/08/22
Hanchang Biotech Co., Ltd. acquired 5.61% stake in Hanju Chemical Company Ltd for KRW 2.7 billion.	27/12/21
Hanju Chemical & Holdings Co., Ltd. announced that it has received KRW 12.49999978 billion in funding from Hanchang Corporation, Jaanh Holdings Co., Ltd., CHOROKBAEM COMPANY Co., Ltd.	29/10/21
Hanju Chemical & Holdings Co., Ltd. announced that it has received KRW 8 billion in funding from Jiyuon Co., Ltd.	21/10/21

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas The Technology Co.,Ltd.

Acciones

A043090

KR7043090000

Otros idiomas

Filtros